Literature DB >> 3967122

Survival following local skin recurrence after mastectomy.

I S Fentiman, P N Matthews, O W Davison, R R Millis, J L Hayward.   

Abstract

Seventy-three patients with breast cancer, treated by radical mastectomy, who subsequently developed a local skin recurrence without clinical evidence of disseminated disease, have been reviewed. There were significant differences between the survival of patients with single and multiple recurrences. Only 10 per cent of those with multiple lesions survived 5 years, and none was alive at 10 years, whereas 42 per cent of those with single lesions survived 5 years and 22 per cent were alive and well at 10 years' postrecurrence. Adequate local treatment of a single skin nodule may enable a subset of patients to survive without subsequent development of breast cancer metastases.

Entities:  

Mesh:

Year:  1985        PMID: 3967122     DOI: 10.1002/bjs.1800720107

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  4 in total

1.  The clinical course of lung metastases from breast cancer.

Authors:  O K Schlappack; M Baur; G Steger; C Dittrich; K Moser
Journal:  Klin Wochenschr       Date:  1988-09-01

2.  Management of screen-detected breast cancer: audit of the first 100 cases in the Southampton and Salisbury breast screening programme.

Authors:  I Campbell; G Royle; R Coddington; A Herbert; C Rubin; I Taylor; P Guyer
Journal:  Ann R Coll Surg Engl       Date:  1993-01       Impact factor: 1.891

3.  Response of cutaneous metastases from breast cancer to capecitabine.

Authors:  Kostandinos Sideras; Katie M Zahasky; Judith S Kaur
Journal:  Clin Med Oncol       Date:  2008-04-18

4.  Palpable Lumps after Mastectomy: Radiologic-Pathologic Review of Benign and Malignant Masses.

Authors:  Rend Al-Khalili; Ali Alzeer; Giang-Kimthi Nguyen; Erin P Crane; Judy H Song; Janice L Jeon; Michael Nellamattathil; Erini V Makariou; Victoria L Mango
Journal:  Radiographics       Date:  2021-05-14       Impact factor: 6.312

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.